Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.09)
# 511
Out of 5,120 analysts
352
Total ratings
43.34%
Success rate
16.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASMB Assembly Biosciences | Assumes: Buy | $50 | $26.37 | +89.61% | 1 | Aug 18, 2025 | |
| ALT Altimmune | Reiterates: Buy | $12 | $5.55 | +116.22% | 19 | Aug 13, 2025 | |
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $500 → $570 | $339.11 | +68.09% | 27 | Aug 7, 2025 | |
| CMPS COMPASS Pathways | Maintains: Buy | $45 → $40 | $6.60 | +506.06% | 17 | Aug 4, 2025 | |
| ATAI AtaiBeckley | Maintains: Buy | $10 → $15 | $3.84 | +290.63% | 20 | Jul 30, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $15.81 | -36.75% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $1.74 | +187.36% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.57 | +1,660.87% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $4.90 | +1,430.61% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $33.04 | +202.66% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $24.70 | +183.40% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.97 | +416.37% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $3.98 | +1,407.54% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $73.00 | +9.59% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $15.79 | +153.32% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $4.00 | +650.00% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $37.84 | +84.99% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.92 | +186.53% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.96 | +410.20% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.48 | +303.23% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $7.71 | +1,326.72% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $78.95 | +7.66% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $12.43 | +447.06% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $112.82 | +201.37% | 1 | Aug 18, 2021 |
Assembly Biosciences
Aug 18, 2025
Assumes: Buy
Price Target: $50
Current: $26.37
Upside: +89.61%
Altimmune
Aug 13, 2025
Reiterates: Buy
Price Target: $12
Current: $5.55
Upside: +116.22%
Alnylam Pharmaceuticals
Aug 7, 2025
Maintains: Buy
Price Target: $500 → $570
Current: $339.11
Upside: +68.09%
COMPASS Pathways
Aug 4, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $6.60
Upside: +506.06%
AtaiBeckley
Jul 30, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $3.84
Upside: +290.63%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $15.81
Upside: -36.75%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $1.74
Upside: +187.36%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.57
Upside: +1,660.87%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $4.90
Upside: +1,430.61%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $33.04
Upside: +202.66%
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $24.70
Upside: +183.40%
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.97
Upside: +416.37%
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $3.98
Upside: +1,407.54%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $73.00
Upside: +9.59%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $15.79
Upside: +153.32%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $4.00
Upside: +650.00%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $37.84
Upside: +84.99%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $27.92
Upside: +186.53%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.96
Upside: +410.20%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $7.71
Upside: +1,326.72%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $78.95
Upside: +7.66%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $12.43
Upside: +447.06%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $112.82
Upside: +201.37%